Back to top

Kestra Medical Technologies Ltd.: Balanced Hold Rating Amid Revenue Growth and EBITDA Challenges

Goldman Sachs analyst David Roman maintained a Hold rating on Kestra Medical Technologies Ltd. today and set a price target of $20.00. David Roman ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Kestra Medical Technologies, Ltd. (KMTS)